Abstract: The present invention is concerned with substituted azole derivatives that selectively modulate regulate and/or inhibit signal transduction mediated by certain native and/or mutant proteine kinases implicated in a variety of human and animal diseases such as cell proliferative metabolic allergic and degenerative disorders. In particular several of these compounds are potent and selective Flt-3 inhibitors or/and syk inhibitors.
| # | Name | Date |
|---|---|---|
| 1 | 6112-DELNP-2012-AbandonedLetter.pdf | 2019-01-04 |
| 1 | Form-5.pdf | 2012-07-24 |
| 2 | Form-3.pdf | 2012-07-24 |
| 2 | 6112-DELNP-2012-FER.pdf | 2018-06-05 |
| 3 | Form-1.pdf | 2012-07-24 |
| 3 | 6112-delnp-2012-Correspondence Others-(06-12-2013).pdf | 2013-12-06 |
| 4 | 6112-delnp-2012-Form-18-(06-12-2013).pdf | 2013-12-06 |
| 4 | 6112-DELNP-2012-Correspondence Others-(14-08-2012).pdf | 2012-08-14 |
| 5 | 6112-delnp-2012-Correspondence Others-(27-11-2012).pdf | 2012-11-27 |
| 5 | 6112-DELNP-2012-GPA-(28-08-2012).pdf | 2012-08-28 |
| 6 | 6112-DELNP-2012-Correspondence-Others-(28-08-2012).pdf | 2012-08-28 |
| 6 | 6112-DELNP-2012-Form-1-(28-08-2012).pdf | 2012-08-28 |
| 7 | 6112-DELNP-2012-Correspondence-Others-(28-08-2012).pdf | 2012-08-28 |
| 7 | 6112-DELNP-2012-Form-1-(28-08-2012).pdf | 2012-08-28 |
| 8 | 6112-delnp-2012-Correspondence Others-(27-11-2012).pdf | 2012-11-27 |
| 8 | 6112-DELNP-2012-GPA-(28-08-2012).pdf | 2012-08-28 |
| 9 | 6112-DELNP-2012-Correspondence Others-(14-08-2012).pdf | 2012-08-14 |
| 9 | 6112-delnp-2012-Form-18-(06-12-2013).pdf | 2013-12-06 |
| 10 | Form-1.pdf | 2012-07-24 |
| 10 | 6112-delnp-2012-Correspondence Others-(06-12-2013).pdf | 2013-12-06 |
| 11 | Form-3.pdf | 2012-07-24 |
| 11 | 6112-DELNP-2012-FER.pdf | 2018-06-05 |
| 12 | Form-5.pdf | 2012-07-24 |
| 12 | 6112-DELNP-2012-AbandonedLetter.pdf | 2019-01-04 |
| 1 | searchstrategy_01-06-2018.pdf |